We should not avoid diclofenac in the treatment of spondyloarthritis.
作者信息
Zingler Gerhard, Herdegen Thomas
机构信息
Medical Department, Former employee of MSD Sharp & Dohme GmbH, Munich, Germany.
Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Kiel, Germany.
出版信息
Ann Transl Med. 2018 Nov;6(Suppl 1):S36. doi: 10.21037/atm.2018.09.42.
Abstract
摘要
相似文献
1
We should not avoid diclofenac in the treatment of spondyloarthritis.在脊柱关节炎的治疗中，我们不应避免使用双氯芬酸。
Ann Transl Med. 2018 Nov;6(Suppl 1):S36. doi: 10.21037/atm.2018.09.42.
2
MI risk associated with naproxen and diclofenac in spondyloarthritis.脊柱关节炎中与萘普生和双氯芬酸相关的心肌梗死风险。
Drug Ther Bull. 2019 Jan;57(1):5. doi: 10.1136/dtb.2018.000050.
3
[MRI of axial spondyloarthritis: diagnostic role and pitfalls].[轴性脊柱关节炎的磁共振成像：诊断作用与陷阱]
Rev Med Suisse. 2016 Mar 9;12(509):495-6, 498-502.
4
Formation of an artifact of diclofenac during acidic extraction of environmental water samples.
J Chromatogr A. 2003 Sep 5;1011(1-2):221-6. doi: 10.1016/s0021-9673(03)01173-7.
5
Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution: Impact of Migraine-Associated Nausea and Prior Triptan Use on Efficacy.两项评估口服溶液双氯芬酸钾的随机、对照3期试验的事后亚组分析：偏头痛相关性恶心和既往曲坦类药物使用对疗效的影响。
Headache. 2017 May;57(5):756-765. doi: 10.1111/head.13073. Epub 2017 Apr 6.
6
Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?轴性脊柱关节炎的结构疾病进展：仍令人担忧？
Curr Rheumatol Rep. 2017 Mar;19(3):14. doi: 10.1007/s11926-017-0639-7.
7
Formation of a Toxic Quinoneimine Metabolite from Diclofenac: A Quantum Chemical Study.双氯芬酸毒性醌亚胺代谢物的形成：一项量子化学研究。
Drug Metab Lett. 2019;13(1):64-76. doi: 10.2174/1872312812666180913120736.
8
INHIBITION OF VIRULENCE FACTORS OF PSEUDOMONAS AERUGINOSA BY DICLOFENAC SODIUM.双氯芬酸钠对铜绿假单胞菌毒力因子的抑制作用
Roum Arch Microbiol Immunol. 2015 Jul-Dec;74(3-4):79-85.
9
Orthodontic tooth movement after inhibition of cyclooxygenase-2.环氧化酶-2抑制后正畸牙齿移动
Am J Orthod Dentofacial Orthop. 2006 Mar;129(3):402-6. doi: 10.1016/j.ajodo.2005.11.020.
10
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.依奇珠单抗，一种白细胞介素-17A 拮抗剂，用于治疗先前未接受生物疾病修饰抗风湿药物（COAST-V）治疗的强直性脊柱炎或放射学中轴型脊柱关节炎患者：一项 3 期随机、双盲、活性对照和安慰剂对照试验的 16 周结果。
Lancet. 2018 Dec 8;392(10163):2441-2451. doi: 10.1016/S0140-6736(18)31946-9. Epub 2018 Oct 22.
本文引用的文献
1
Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis.在患有脊柱关节炎和骨关节炎的患者中使用某些非甾体抗炎药的心肌梗死风险。
Ann Rheum Dis. 2018 Aug;77(8):1137-1142. doi: 10.1136/annrheumdis-2018-213089. Epub 2018 Apr 19.
2
Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis.类风湿关节炎、银屑病关节炎和中轴型脊柱关节炎主要不良心血管事件的发生率和患病率。
Arthritis Care Res (Hoboken). 2018 Dec;70(12):1756-1763. doi: 10.1002/acr.23567.
3
Effects of nonsteroidal anti-inflammatory drugs on serum proinflammatory cytokines in the treatment of ankylosing spondylitis.非甾体抗炎药对强直性脊柱炎治疗中血清促炎细胞因子的影响。
Biochem Cell Biol. 2018 Aug;96(4):450-456. doi: 10.1139/bcb-2017-0267. Epub 2018 Jan 11.
4
Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis: A Randomized Clinical Trial.骨关节炎和类风湿关节炎患者使用非甾体抗炎药的安全性差异：一项随机临床试验。
Arthritis Rheumatol. 2018 Apr;70(4):537-546. doi: 10.1002/art.40400.
5
Cardioprotective Effect of NSAIDs.非甾体抗炎药的心脏保护作用。
Dtsch Arztebl Int. 2017 Aug 21;114(33-34):559. doi: 10.3238/arztebl.2017.0559b.
6
Cardiovascular risk in patients with rheumatoid arthritis.类风湿关节炎患者的心血管风险
Semin Immunopathol. 2017 Jun;39(4):447-459. doi: 10.1007/s00281-017-0632-2. Epub 2017 Apr 28.
7
Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis.一般人群中与主要类型关节炎相关的心肌梗死事件：系统评价和荟萃分析。
Ann Rheum Dis. 2017 Aug;76(8):1396-1404. doi: 10.1136/annrheumdis-2016-210275. Epub 2017 Feb 20.
8
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.2016 年更新的 ASAS-EULAR 中轴型脊柱关节炎管理推荐。
Ann Rheum Dis. 2017 Jun;76(6):978-991. doi: 10.1136/annrheumdis-2016-210770. Epub 2017 Jan 13.
9
Cardiovascular adverse events by non-steroidal anti-inflammatory drugs: when the benefits outweigh the risks.非甾体抗炎药引起的心血管不良事件：何时获益大于风险。
Expert Rev Clin Pharmacol. 2016 Nov;9(11):1479-1492. doi: 10.1080/17512433.2016.1230495. Epub 2016 Sep 8.
10
Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality: A Population-Based Study.强直性脊柱炎患者的心血管和脑血管死亡率增加：一项基于人群的研究。
Ann Intern Med. 2015 Sep 15;163(6):409-16. doi: 10.7326/M14-2470.
Zotero 插件